Alcaliber Revenue and Competitors
Estimated Revenue & Valuation
- Alcaliber's estimated annual revenue is currently $36M per year.
- Alcaliber's estimated revenue per employee is $201,000
Employee Data
- Alcaliber has 179 Employees.
- Alcaliber grew their employee count by 23% last year.
Alcaliber's People
Name | Title | Email/Phone |
---|
Alcaliber Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.5M | 102 | 4% | N/A | N/A |
#2 | $23.9M | 119 | 43% | N/A | N/A |
#3 | $10.5M | 52 | 0% | N/A | N/A |
#4 | $40.2M | 200 | 24% | N/A | N/A |
#5 | $59.3M | 295 | 6% | N/A | N/A |
#6 | $8.8M | 44 | N/A | N/A | N/A |
#7 | $42.8M | 213 | 16% | N/A | N/A |
#8 | $49.6M | 247 | 11% | N/A | N/A |
#9 | $157.4M | 783 | 6% | N/A | N/A |
#10 | $36M | 179 | 23% | N/A | N/A |
What Is Alcaliber?
Alcaliber S.A. is a pharmaceuticals company based out of 3 Calle General Moscardó, Madrid, Community of Madrid, Spain.
keywords:N/AN/A
Total Funding
179
Number of Employees
$36M
Revenue (est)
23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Alcaliber News
2022-04-20 - Global Morphine Market 2022-2028 Demand, Key Regions ...
Alcaliber; Purdue Pharma; Sanofi Winthrop Industrie; Macfarlan Smith; Sun Pharmaceutical Industries; Qinghai Pharmaceutical; Northeast...
2022-04-19 - Global Morphine Market 2022 Industry Insights and Major ...
Alcaliber; Purdue Pharma; Sanofi Winthrop Industrie; Macfarlan Smith; Sun Pharmaceutical Industries; Qinghai Pharmaceutical; Northeast...
2022-04-19 - Thebaine Consumption Market Growth 2022-2029| Key ...
Noramco; Alcaliber; Tasmanian Alkaloids; TPI; Cepia-Sanofi; Taj Pharmaceuticals; API Labs; Faran Shimi Pharmaceuticals; Gansu Alkaloids; Hwells.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $49.4M | 179 | 50% | N/A |
#2 | $43.3M | 179 | 36% | N/A |
#3 | $35.4M | 179 | 25% | N/A |
#4 | $65.3M | 180 | 3% | N/A |
#5 | $40.2M | 181 | 21% | N/A |